Cioms V Narrative Template ##VERIFIED##
Download ---> https://blltly.com/2ttOgW
How to Write a Clinical Narrative Using the Cioms V Template
A clinical narrative is a detailed description of a patient's medical history, diagnosis, treatment, and outcome. It is usually written by a health care professional to document a clinical event or case. A clinical narrative can be used for various purposes, such as reporting adverse drug reactions, submitting periodic drug safety updates, or publishing case reports.
One of the challenges of writing a clinical narrative is to organize and present the information in a clear and concise way. A common format for writing a clinical narrative is the Cioms V template, which was developed by the Council for International Organizations of Medical Sciences (CIOMS) Working Group V on pharmacovigilance. The Cioms V template provides a standard structure and content for clinical narratives, as well as guidance on how to write them.
The Cioms V template consists of four main sections: patient information, adverse event information, drug information, and narrative summary. Each section has a number of sub-sections that specify the data elements that should be included in the narrative. The following table summarizes the Cioms V template:
Section
Sub-section
Data element
Patient information
Patient identifier
A unique code or number assigned to the patient
Patient demographics
Age, sex, weight, height, race/ethnicity
Relevant medical history
Pre-existing conditions, allergies, family history, etc.
Relevant laboratory data
Results of tests or investigations related to the adverse event or drug exposure
Adverse event information
Adverse event term
The name of the adverse event using a standardized terminology (e.g., MedDRA)
Adverse event onset date and time
The date and time when the adverse event first occurred or was noticed
Adverse event outcome date and time
The date and time when the adverse event resolved, improved, worsened, or became fatal
Adverse event seriousness criteria
The criteria that make the adverse event serious according to the regulatory definition (e.g., death, life-threatening, hospitalization, disability, congenital anomaly, etc.)
Adverse event intensity/severity
The degree of severity of the adverse event using a standardized scale (e.g., mild, moderate, severe)
Drug informationSuspect drug(s)The name(s) of the drug(s) suspected to have caused or contributed to the adverse eventSuspect drug indication(s)The reason(s) why the suspect drug(s) were prescribed or used by the patientSuspect drug start date and timeThe date and time when the patient first started taking the suspect drug(s)Suspect drug stop date and timeThe date and time when the patient stopped taking the suspect drug(s)Suspect drug dose and frequencyThe amount and frequency of the suspect drug(s) taken by the patientSuspect drug route of administrationThe way the suspect drug(s) were administered to the patient (e.g., oral, intravenous, etc.)Concomitant drug(s)Concomitant drug name(s)The name(s) of any other drug(s) taken by the patient at the same time as the suspect drug(s)Concomitant drug indication(s)The reason(s) why the concomitant drug(s) were prescribed or used by the patient 248dff8e21